LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor

Journal: Cell Metabolism

Published: 2017-12-07

DOI: 10.1016/j.cmet.2017.10.016

Affiliations: 3

Authors: 16

Go to article
Institutions FC
NGM Biopharmaceuticals, Inc., United States of America (USA) 0.69
Department of Cardiovascular and Metabolic Disease, MD, United States of America (USA) 0.22
MedImmune, LLC. UK, United Kingdom (UK) 0.09

Return